US regulators are looking to infuse a relatively new regulatory data harmonization group with some major funding to help support several regulatory initiatives, including therapeutic area data ...
The US Food and Drug Administration (FDA) has released draft guidance for industry that outlines the agency’s thinking on how a sponsor should submit drug and biological product study data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results